Vocal cord paralysis in myasthenia gravis with anti-MuSK antibodies.
Hara
K
K
Department of Neurology, Brain Research Institute, Niigata University, 1-757 Asahi-machi-dori, Niigata, 951-8585, Japan.
Mashima
T
T
Matsuda
A
A
Tanaka
K
K
Tomita
M
M
Shiraishi
H
H
Motomura
M
M
Nishizawa
M
M
D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D010244:Bulbar Palsy, Progressive / Q000097:blood / Q000276:immunology / Q000503:physiopathology; D003680:Deglutition Disorders / Q000097:blood / Q000276:immunology / Q000503:physiopathology; D005152:Facial Muscles / Q000294:innervation / Q000503:physiopathology; D006801:Humans; D007821:Laryngeal Muscles / Q000294:innervation / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D018908:Muscle Weakness / Q000097:blood / Q000276:immunology / Q000503:physiopathology; D009157:Myasthenia Gravis / Q000150:complications* / Q000276:immunology / Q000503:physiopathology*; D009469:Neuromuscular Junction / Q000276:immunology / Q000503:physiopathology; D011239:Prednisolone / Q000627:therapeutic use; D020794:Receptor Protein-Tyrosine Kinases / Q000276:immunology*; D011950:Receptors, Cholinergic / Q000276:immunology*; D012131:Respiratory Insufficiency / Q000097:blood / Q000276:immunology / Q000503:physiopathology; D014139:Tracheostomy; D016896:Treatment Outcome; D014826:Vocal Cord Paralysis / Q000097:blood / Q000276:immunology* / Q000503:physiopathology
D001323:Autoantibodies; D015415:Biomarkers; D011950:Receptors, Cholinergic; D011239:Prednisolone; C095714:MUSK protein, human; D020794:Receptor Protein-Tyrosine Kinases